All News

Gene Editing

Gene Editing: Tools and Technology of the Future
11 January 2023
Gene Editing: Tools and Technology of the Future
For this interview, Phacilitate’s Becky
Early Considerations for Commercial Success
4 January 2023
Early Considerations for Commercial Success
For this interview, Phacilitate’s Becky
Genome Editing Tools and Techniques for Cancer Therapies
3 January 2023
Genome Editing Tools and Techniques for Cancer Therapies
For this interview, Phacilitate’s Ryan
Improving Novel Theraputics and Early-Phase Trials
5 December 2022
Improving Novel Theraputics and Early-Phase Trials
For this interview, Phacilitate’s Ryan
POPULAR NEWS ITEMS
Image
3 February 2023

Navigating the Applications of Title21’s Manufacturing Execution System

Image
2 February 2023

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image
1 February 2023

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer

Commercial Considerations in the World of Rare Diseases
5 December 2022
Commercial Considerations in the World of Rare Diseases
For this interview, Phacilitate’s Becky
“Endowing Cells with Super-Physical Properties” to Better Treat Patient Populations
29 November 2022
“Endowing Cells with Super-Physical Properties” to Better Treat Patient Populations
For this interview, Phacilitate’s Ryan
The Advanced Therapies Workforce Evolution
29 November 2022
The Advanced Therapies Workforce Evolution
For this interview, Phacilitate’s Becky
Creative Mechanisms for Growing the Biomanufacturing Industry
29 November 2022
Creative Mechanisms for Growing the Biomanufacturing Industry
Jenny Ligon, Associate Director of
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Navigating the Applications of Title21’s Manufacturing Execution System

Image

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer